Showing results (81-90 of 196) with videos related to
Sort By:
Pageof 20
The American Journal of Psychiatry|February 15, 2000
Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia GroupR Howard, P V Rabins, M V Seeman, et al.International Journal of Geriatric Psychiatry|September 14, 2000
Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnosesE Rockwell, J Choure, D Galasko, et al.Journal of Clinical Psychopharmacology|August 1, 1988
Pharmacological treatments of tardive dyskinesia in the 1980sD V Jeste, J B Lohr, K Clark, et al.Psychopharmacology|January 1, 1982
Serum neuroleptic concentrations and tardive dyskinesiaD V Jeste, M Linnoila, R L Wagner, et al.Psychopharmacology|June 1, 1997
A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical SettingD V Jeste, M Klausner, M Brecher, et al.The Journal of Clinical Psychiatry|September 1, 1991
New-onset psychosis in HIV-infected patientsM J Harris, D V Jeste, A Gleghorn, et al.Psychopharmacology|January 1, 1984
Pharmacogenetics of phenylethylamine: determination of heritability and genetic transmission of locomotor effects in recombinant inbred strains of miceD V Jeste, D M Stoff, R Rawlings, et al.Schizophrenia Research|January 7, 1998
Effects of schizophrenia and aging on pupillographic measures of working memoryS K Morris, E Granholm, A J Sarkin, et al.Life Sciences|March 1, 1982
Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patientsN R Cutler, D V Jeste, F Karoum, et al.Molecular Psychiatry|May 13, 2003
Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotypeR A Sweet, V L Nimgaonkar, B Devlin, et al.Pageof 20